Latest MS research news

Latest MS research news | 03 March 2014

Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years

The results from this study show that a combined numerical score of motor and visual evoked potentials measures allows prediction of the development of long-term clinical disability after 20 years in MS patients.

From MSIF

Latest MS research news | 25 February 2014

Investigation of outer cortical magnetisation transfer ratio abnormalities

The outer grey matter layer of the brain, called the cortex, often contains demyelinating lesions in MS patients. This study group used a specific type of MRI sequence (called magnetization transfer ratio (MTR)), to image this outer layer of the brain

From MSIF

Latest MS research news | 25 February 2014

Brain atrophy and disability progression in MS patients: A 10-year follow-up study

This prospective study looked at the association between MRI measures of global and tissue-specific damage and disability progression.

From MSIF

Latest MS research news | 25 February 2014

Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in MS

The researchers in this study showed that the presence of a certain inflammatory protein in the spinal fluid of patients with relapsing remitting MS

From MSIF

Latest MS research news | 18 February 2014

Effect of oral cladribine on time to conversion to clinically definite MS

This trial for early signs of MS, investigated the effect of oral cladribine on conversion to clinically definite MS in patients with a first clinical demyelinating event, when given at the same doses shown to be effective in relapsing MS.

From MSIF

Latest MS research news | 18 February 2014

Neurofilament light antibodies in serum reflect response to natalizumab treatment in MS

This study group looked at components/proteins of neurons, and the role of antibodies against these proteins (neurofilament light protein), as biomarkers for monitoring response to treatment and their correlation with the different types of MS.

From MSIF

Latest MS research news | 18 February 2014

TIRC7 and HLA-DR axis contributes to inflammation in MS

This study looked at the role of a certain cell surface protein (TIRC7) in inflammation in MS. The results demonstrated that the activation of this protein resulted in the activation of lymphocyte proliferation which promotes inflammation in multiple sclerosis.

From MSIF

Latest MS research news | 11 February 2014

Diagnostic uncertainty during the transition to secondary progressive MS

This study looked at the diagnosis of the transition from relapsing remitting MS (RRMS) to secondary progressive MS (SPMS). A period of diagnostic uncertainty regarding the transition existed in many of the patients in this study.

From MSIF

Latest MS research news | 11 February 2014

Epstein-Barr virus-specific adoptive immunotherapy for progressive MS

A lot of evidence to date indicates that infection with Epstein-Barr virus (which causes glandular fever), has a role in the causation of MS. This study demonstrated that immunotherapy with EBV-specific T cells was associated with an improvement in patient symptoms and there was a reduction in disease activity on MRI with no side-effects.

From MSIF

Latest MS research news | 11 February 2014

Interaction between adolescent obesity and HLA risk genes in the etiology of MS

This study looked at the potential interaction between adolescent obesity and the genes most strongly associated with MS. The researchers found interactions between adolescent obesity and two potent MS risk genes.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research